8 12. Conclusion The resource allocation of infertility services available for patients is asymmetric, with the highest levels in the larger cities. The evidence reviewed suggests that IUI may be helpful in a low-technology medical setting. It may be considered as a good ﬁrst-line treatment for couples with unexplained infertility, male factor infertility, and anovu- lation (IUI used concurrently with ovulation induction). In the clinical practice of IUI in a low-technology setting, combining oral clomiphene with IUI is as reasonable of an option as natural cycle IUI. For semen parameters, a motile sperm count above 1 million in the ﬁnal specimen can serve as a cutoﬀ point for oﬀering IUI. Conventional sperm washing, density gradient centrifugation, or swim- up techniques can all be used for sperm preparation before IUI, with conventional sperm washing being the simplest. A single IUI per cycle should be performed, and the IUI can be performed approximately 24 hours after urinary LH surge is detected. Couples may be oﬀered 3 to 6 IUI cycles to ensure suﬃcient opportunity to achieve pregnancy. References [1] C. Keck, C. Gerber-Schafer, C. Wilhelm, D. Vogelgesang, and M. Breckwoldt, “Intrauterine insemination for treatment of male infertility,” International Journal of Andrology, vol. 20, supplement 3, pp. 55–64, 1997. [2] W. Ombelet, K. Deblaere, E. Bosmans, et al., “Semen quality and intrauterine insemination,” Reproductive BioMedicine Online, vol. 7, no. 4, pp. 485–492, 2003. [3] J. U. Klein, D. Kuleta, and J. C. Petrozza, “Intrauterine insemination (IUI) outcomes in cases performed by nurses as compared with cases performed by physicians,” Fertility and Sterility, vol. 88, supplement 1, pp. S9–S10, 2007. [4] J. Boivin, L. Bunting, J. A. Collins, and K. G. Nygren, “Inter- national estimates of infertility prevalence and treatment- seeking: potential need and demand for infertility medical care,” Human Reproduction, vol. 22, no. 6, pp. 1506–1512, 2007. [5] E. H. Stephen and A. Chandra, “Use of infertility services in the United States: 1995,” Family Planning Perspectives, vol. 32, no. 3, pp. 132–137, 2000. [6] J. C. Abma, A. Chandra, W. D. Mosher, L. S. Peterson, and L. J. Piccinino, “Fertility, family planning, and women’s health: new data from the 1995 National Survey of Family Growth,” Vital and Health Statistics, vol. 23, no. 19, pp. 1–114, 1997. [7] D. W. Stovall, B. D. Allen, A. E. T. Sparks, C. H. Syrop, R. G. Saunders, and B. J. Van Voorhis, “The cost of infertility evaluation and therapy: ﬁndings of a self-insured university healthcare plan,” Fertility and Sterility, vol. 72, no. 5, pp. 778– 784, 1999. [8] B. J. Oddens, I. den Tonkelaar, and H. Nieuwenhuyse, “Psy- chosocial experiences in women facing fertility problems—a comparative survey,” Human Reproduction, vol. 14, no. 1, pp. 255–261, 1999. [9] A. D. Domar, P. C. Zuttermeister, and R. Friedman, “The psychological impact of infertility: a comparison with patients with other medical conditions,” Journal of Psychosomatic Obstetrics and Gynaecology, vol. 14, supplement, pp. 45–52, 1993. Obstetrics and Gynecology International [10] P. Thiering, J. Beaurepaire, M. Jones, D. Saunders, and C. Ten- nant, “Mood state as a predictor of treatment outcome after in vitro fertilization/embryo transfer technology (IVF/ET),” Journal of Psychosomatic Research, vol. 37, no. 5, pp. 481–491, 1993. [11] Society for Assisted Reproductive Technology, American Society for Reproductive Medicine, “Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry,” Fertility and Sterility, vol. 87, no. 6, pp. 1253–1266, 2007. [12] A. Nyboe Andersen, V. Goossens, L. Gianaroli, R. Felberbaum, J. de Mouzon, and K. G. Nygren, “Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE,” Human Reproduction, vol. 22, no. 6, pp. 1513–1525, 2007. [13] J. Collins, “Cost-eﬀectiveness of in vitro fertilization,” Sem- inars in Reproductive Medicine, vol. 19, no. 3, pp. 279–289, 2001. [14] U. M. Reddy, R. J. Wapner, R. W. Rebar, and R. J. Tasca, “Infer- tility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop,” Obstetrics and Gynecology, vol. 109, no. 4, pp. 967–977, 2007. [15] V. C. Wright, J. Chang, G. Jeng, and M. Macaluso, “Assisted reproductive technology surveillance—United States, 2003,” MMWR. Surveillance Summaries, vol. 55, no. SS04, pp. 1–22, 2006. [16] R. A. Jackson, K. A. Gibson, Y. W. Wu, and M. S. Croughan, “Perinatal outcomes in singletons following in vitro fertiliza- tion: a meta-analysis,” Obstetrics and Gynecology, vol. 103, no. 3, pp. 551–563, 2004. [17] A. Schreurs, E. Legius, C. Meuleman, J.-P. Fryns, and T. M. D’Hooghe, “Increased frequency of chromosomal abnor- malities in female partners of couples undergoing in vitro fertilization or intracytoplasmic sperm injection,” Fertility and Sterility, vol. 74, no. 1, pp. 94–96, 2000. [18] M. Hansen, J. J. Kurinczuk, C. Bower, and S. Webb, “The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization,” The New England Journal of Medicine, vol. 346, no. 10, pp. 725–730, 2002. [19] W. Ombelet, P. Puttemans, and E. Bosmans, “Intrauterine insemination: a ﬁrst-step procedure in the algorithm of male subfertility treatment,” Human Reproduction, vol. 10, supplement 1, pp. 90–102, 1995. [20] M. Gaudoin, R. Dobbie, A. Finlayson, J. Chalmers, I. T. Cameron, and R. Fleming, “Ovulation induction/intrauterine insemination in infertile couples is associated with low-birth- weight infants,” American Journal of Obstetrics & Gynecology, vol. 188, no. 3, pp. 611–616, 2003. [21] S. Nuojua-Huttunen, M. Gissler, H. Martikainen, and L. Tuomivaara, “Obstetric and perinatal outcome of pregnancies after intrauterine insemination,” Human Reproduction, vol. 14, no. 8, pp. 2110–2115, 1999. [22] J. Hoy, A. Venn, J. Halliday, G. Kovacs, and K. Waalwyk, “Perinatal and obstetric outcomes of donor insemination using cryopreserved semen in Victoria, Australia,” Human Reproduction, vol. 14, no. 7, pp. 1760–1764, 1999. [23] N. C. Allen, C. M. Herbert III, W. S. Maxson, B. J. Rogers, M. P. Diamond, and A. C. Wentz, “Intrauterine insemination: a critical review,” Fertility and Sterility, vol. 44, no. 5, pp. 569– 580, 1985. [24] K. Ahinko-Hakamaa, H. Huhtala, and H. Tinkanen, “Success in intrauterine insemination: the role of etiology,” Acta